Tissue Regeneration gets FDA OK for 3D-printed cranial reconstruction device

09/3/2013 | MassDevice.com (Boston)

The FDA has cleared Tissue Regeneration Systems to market its Cranial Bone Void Filler, a 3D-printed cranial reconstruction device used to close holes in the skulls of patients who have undergone surgery. "To our knowledge, this is the first FDA approval of a coated bioresorbable skeletal reconstruction implant fabricated by means of 3D printing," said Jim Fitzsimmons, the company's president and CEO.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI